Research Abstract: Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection

Date Published: June 11, 2019

Publisher: Public Library of Science

Author(s): Lucía Pastor, Jost Langhorst, Dorit Schröder, Aina Casellas, Andreas Ruffer, Jorge Carrillo, Victor Urrea, Sergio Massora, Inacio Mandomando, Julià Blanco, Denise Naniche, Aftab A. Ansari.

http://doi.org/10.1371/journal.pone.0218000

HIV (human immunodeficiency virus) is a virus that attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases. It is spread by contact with certain bodily fluids of a person with HIV, most commonly during unprotected sex (sex without a condom or HIV medicine to prevent or treat HIV), or through sharing injection drug equipment.
Zonulin is a protein that modulates the permeability of tight junctions between cells of the wall of the digestive tract.

Abstract

Primary HIV infection (PHI) is the initial phase after HIV acquisition characterized by high viral replication, massive inflammatory response and irreversible immune-damage, particularly at the gastrointestinal level. In this study we aimed to characterize the dynamics of gastrointestinal damage biomarkers during the different phases of HIV infection and assess their association with HIV-disease markers and their accuracy to differentiate PHI from chronic HIV infection (CHI).

PHI-individuals (n = 57) were identified as HIV-seronegative/HIV-RNA positive and were followed up for one year at the Manhiça District Hospital in Mozambique. Ten plasma and 12 stool biomarkers were quantified by Luminex or ELISA and levels were compared to CHI-naive (n = 26), CHI on antiretroviral-treatment (ART; n = 30) and HIV-uninfected individuals (n = 58). Regression models adjusted by time point were used to estimate the association of the biomarkers with HIV-disease markers. Receiver operating curves were compared for the best accuracy to distinguish PHI from CHI.

Soluble (s)CD14 was significantly associated with the CD4/CD8 ratio (P < 0.05) and viremia levels (P < 0.0001) during PHI. Plasma zonulin and stool lactoferrin were significantly higher in PHI as compared to CHI-individuals (P < 0.05). Plasma zonulin demonstrated the best accuracy to identify PHI among HIV-infected individuals (AUC = 0.85 [95% CI 0.75–0.94]). Using a cutoff value of plasma zonulin ≥ 8.75 ng/mL the model identified PHI with 87.7% sensitivity (95% CI 76.3–94.9) and 69.2% specificity (95% CI 48.2–85.7). An adjusted multivariate model including age, plasma zonulin and sCD14 further increased the classification performance (AUC = 0.92 [95% CI 0.86–0.99]).

While the stool biomarkers did not provide any predictive ability to distinguish PHI from CHI-individuals, plasma sCD14 and zonulin were significantly associated with HIV-disease markers and PHI identification, respectively. These inflammatory biomarkers may be useful to monitor changes in gastrointestinal integrity during HIV infection.

Source:

http://doi.org/10.1371/journal.pone.0218000

https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids

Vanuytsel, T; et al. (Dec 2013). “The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease”Tissue Barriers1 (5): e27321. doi:10.4161/tisb.27321PMC 3943850PMID 24868498.


Advertisements
Advertisements


Keywords: zonulin, HIV, gastrointestinal damage, complication, biomarkers, plasma

Leave a Reply

Your email address will not be published.